March marks Autoimmune Awareness Month, a time dedicated to understanding how autoimmune disorders affect patients and health systems. A normal, healthy immune system protects the organs by warding off infection and cell mutation. Autoimmune conditions attack healthy tissue and organs, creating symptoms that range from minor irritations to debilitating symptoms that require lifelong care.
One in seven Americans — more than 50 million, most of them women — are living with these conditions. Some are familiar: lupus, rheumatoid arthritis and multiple sclerosis have received media attention around advocacy and fundraising. Still others are unfamiliar outside of small communities of specialists. Some of these lesser known and rare conditions include IgG4-related disease, eosinophilic granulomatosis and takayasu arteritis. All conditions impact patients’ day-to-day activities, and many can lead to chronic pain and long-term bodily damage if not diagnosed and treated promptly.
Awareness efforts should surround not only the diseases themselves but also draw attention to the barriers patients encounter while seeking care.
Complex Conditions Require Tailored Care
Each autoimmune condition presents its own challenges. Some symptoms and conditions can be treated by common, well-known medicines like aspirin and insulin. Others rely on advanced therapies like biologics, which bring relief by targeting specific immune pathways and triggers. These treatments slow disease progression, making degenerative diseases into manageable chronic conditions.
- Juvenile idiopathic arthritis was once life-threatening, with joint damage making normal childhood play impossible. Now most patients achieve complete disease remission.
- Neuromyelitis optica spectrum disorder and Behçet’s disease both cause rapidly increasing blindness. Biologics reduce relapses by 70-90%.
- Muckle–Wells syndrome causes chronic inflammation, hearing loss and kidney failure, but biologic treatments have reduced serious complications and restored near-normal life expectancy.
- Lupus treatment has improved dramatically with targeted therapies, reducing organ damage from the disease and also from the other leading treatment: high-dose steroids.
Unfortunately, many patients struggle to access these transformative advancements in treatment.
Coverage Limits Restrict Treatment Options
Some challenges in treating autoimmune disorders are unavoidable. Shortages of specialists, geographic distance, low disease incidence and complex symptom profiles can make diagnosis and treatment difficult. A single patient may have a rheumatologist, an endocrinologist and a dermatologist, all coordinating to manage symptoms.
Innovative treatments also can have a sizable price tag. Insurance companies often use utilization management tools to control spending, as when they require prior authorization or step-therapy protocols before new treatments can be accessed. For patients with autoimmune conditions, these administrative delays can mean declining function and worsening symptoms.
Patients with autoimmune conditions are living in an exciting time of scientific advancement, but it will matter little for those who are unable to get access to care. During this Autoimmune Awareness Month, it’s important to highlight more responsive systems and clearer pathways to treatment that can further enhance outcomes for patients in need.
